274 results
SC 14D9
CTIC
CTI BioPharma Corp
25 May 23
Tender offer solicitation
7:00am
of Company Options in the Transactions.”
The amount listed in this column represents the value of health care premiums that would be due to the named
SC TO-T
EX-99
CTIC
CTI BioPharma Corp
25 May 23
Third party tender offer statement
6:46am
at Investor AB, Financial analyst at Goldman Sachs and board member of Aleris and Mölnlycke Health Care.
Staffan Schüberg
Sweden
Director
Mr. Schüberg
SC14D9C
EX-2.1
CTIC
CTI BioPharma Corp
10 May 23
Written communication relating to third party tender offer
1:30pm
Law (42 U.S.C. § 1320a-7a(a)(5)) and the health care fraud criminal provisions of the Health Insurance Portability and Accountability Act of 1996 (42
8-K
EX-2.1
CTIC
CTI BioPharma Corp
10 May 23
Tender and Support Agreement
8:05am
Law (42 U.S.C. § 1320a-7a(a)(5)) and the health care fraud criminal provisions of the Health Insurance Portability and Accountability Act of 1996 (42
8-K
EX-1.1
r9uxej0 bht9d9jl7i
6 Apr 21
Entry into a Material Definitive Agreement
4:02pm
424B5
q6v33tj
14 Feb 20
Prospectus supplement for primary offering
8:14am
424B5
97tnmfqgrtkc2x
15 Nov 19
Prospectus supplement for primary offering
4:12pm